Logo

• Finished gynecological cancer (KGOG3008)

  The Efficacy of 3rd line Chemotherapeutic Agent in Patients with Recurrent Epithelial Ovarian Cancer Using by 3D HDRA: Open-label, Prospective Study

  • PI / PI기관 Yong Man Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 48 person (0.0%)

• Finished gynecological cancer (KGOG3007)

  Effects and Safety of Parenteral Iron [Venoferrum® (iron sucrose)] as an Adjunct to Erythropoietic Agent [Recormon® (Epoetin-β)] Therapy in Ovarian Cancer Patients for the Management of Chemotherapy-Related Anemia : Prospective, Multicenter, Open-Label, Randomized Trial

  • PI / PI기관 Seung Cheol Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 80 person (0.0%)

• Finished gynecological cancer (KGOG3006)

  An Evaluation of Efficacy and Adverse Effects of Belotecan(Camtobell®) in Patients with Recurrent and Refractory Ovarian Cancer

  • PI / PI기관 Yong Man Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 100 person / 44 person (227.3%)

• Finished gynecological cancer (KGOG3005)

  Retrospective-A clinicopathologic analysis of pseudomyxoma peritonei

  • PI / PI기관 Jae-Kwan Lee /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 52 person / 0 person (0.0%)

• Finished gynecological cancer (KGOG3004)

  Comparative study of treatment modalities for Malignant Ovarian Germ cell tumor in Korea; Multicenter Retrospective study

  • PI / PI기관 Ki Heon Lee /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 326 person / 0 person (0.0%)

• Finished gynecological cancer (KGOG3003)

  Retrospective-Clear cell carcinoma (CCC) of the ovary

  • PI / PI기관 Sang-Young Ryu /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 205 person / 150 person (136.7%)

• Finished gynecological cancer (KGOG3002)

  • PI / PI기관 Ki Heon Lee /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)

• Finished gynecological cancer (KGOG3001)

  An Open label, Single arm and Multi-center Phase II Clinical Trial of Gemcitabine Triplet (Paclitaxel + Carboplatin + Gemcitabine) as Consolidation Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

  • PI / PI기관 Seung Cheol Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 69 person (0.0%)

• Finished gynecological cancer (KGOG2028)

  • PI / PI기관 Min Kyu Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)

• Finished gynecological cancer (KGOG2026)

  RACHAEL PRO: Rate of occult atypical hyperplasia or cancer in women with non-atypical endometrial hyperplasia

  • PI / PI기관 Kidong Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 184 person (0.0%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.